Concord Drugs Ltd - 538965 - Shareholding for the Period Ended June 30, 2019
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here22-07-2019
22-07-2019
Concord Drugs Ltd - 538965 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S. Nagi ReddyDesignation :- Director20-07-2019
Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy25-06-2019
Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy25-06-2019
Concord Drugs Ltd - 538965 - Closure of Trading Window
The trading window for dealing in the securities of the Company will remain closed from 30th June, 2019 till 48 hours after the declaration of financial results for the quarter ended 30.06.201924-06-2019
Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Manoj Kumar Reddy24-06-2019
Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Koni Reddy24-06-2019
Concord Drugs Ltd - 538965 - Non Applicability Of Secretarial Compliance Report For The Year Ended 31.03.2019
Non applicability of secretarial compliance report for the year ended 31.03.201931-05-2019
Concord Drugs Ltd - 538965 - Audited Financial Results For The Quarter And Year Ended 31.03.2019
Audited financial results for the quarter and year ended 31.03.201930-05-2019